A1 Refereed original research article in a scientific journal
CoNECo: a Corpus for Named Entity recognition and normalization of protein Complexes
Authors: Nastou, Katerina; Koutrouli, Mikaela; Pyysalo, Sampo; Jensen, Lars Juhl
Editors: Zhu Shanfeng
Publisher: Oxford University Press (OUP)
Publishing place: OXFORD
Publication year: 2024
Journal: Bioinformatics Advances
Journal name in source: Bioinformatics Advances
Journal acronym: BIOINFORM ADV
Article number: vbae116
Volume: 4
Issue: 1
Number of pages: 7
eISSN: 2635-0041
DOI: https://doi.org/10.1093/bioadv/vbae116
Web address : https://doi.org/10.1093/bioadv/vbae116
Self-archived copy’s web address: https://research.utu.fi/converis/portal/detail/Publication/458834899
Motivation
Despite significant progress in biomedical information extraction, there is a lack of resources for Named Entity Recognition (NER) and Named Entity Normalization (NEN) of protein-containing complexes. Current resources inadequately address the recognition of protein-containing complex names across different organisms, underscoring the crucial need for a dedicated corpus.
Results
We introduce the Complex Named Entity Corpus (CoNECo), an annotated corpus for NER and NEN of complexes. CoNECo comprises 1621 documents with 2052 entities, 1976 of which are normalized to Gene Ontology. We divided the corpus into training, development, and test sets and trained both a transformer-based and dictionary-based tagger on them. Evaluation on the test set demonstrated robust performance, with F-scores of 73.7% and 61.2%, respectively. Subsequently, we applied the best taggers for comprehensive tagging of the entire openly accessible biomedical literature.
Availability and implementation
All resources, including the annotated corpus, training data, and code, are available to the community through Zenodo https://zenodo.org/records/11263147 and GitHub https://zenodo.org/records/10693653.
Downloadable publication This is an electronic reprint of the original article. |
Funding information in the publication:
This work was supported by the Novo Nordisk Foundation [NNF14CC0001, NNF20SA0035590 to M.K.], the Academy of Finland [332844], and the European Union's Horizon 2020 research and innovation programme under the Marie Sklodowska-Curie [101023676 to K.N.].